Safety assessment of Osilodrostat: The adverse event analysis based on FAERS database by means of disproportionality analysis.
<h4>Background</h4>Osilodrostat is a medication recently approved for the treatment of Cushing's syndrome. However, there is a current dearth of large-scale studies on the adverse events associated with Osilodrostat. Consequently, this study aims to comprehensively evaluate these ad...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0329088 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|